12,500,000 Shares ANTARES PHARMA, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 4th, 2012 • Antares Pharma, Inc. • Surgical & medical instruments & apparatus • New York
The Company has prepared and filed in conformity with the requirements of the Securities Act of 1933, as amended (the “Securities Act”), and the published rules and regulations thereunder (the “Rules”) adopted by the Securities and Exchange Commission (the “Commission”) a “shelf’ registration statement on Form S-3 (No. 333-167975), which became effective as of July 21, 2010, including a base prospectus (the “Base Prospectus”) relating to common stock, preferred stock and warrants of the Company that may be sold from time to time by the Company in accordance with Rule 415 of the Securities Act, and such amendments
